PTC Therapeutics, Inc. (PTCT) Valuation — DCF & Advanced Analysis | MarketCI

PT

PTCT

Market Closed

PTC Therapeutics, Inc.

US

939 employees

CEO: Matthew Klein

Founded: 2013

$75.14

+$0.00(+NaN%)

Market Cap

6.23B

Beta

0.55

52W Range

N/A

Dividend Yield

0.00%

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: No specific insights available at this time.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore PTCT

Key metrics and AI-powered insights

Price targets and earnings estimates

Income, balance sheet and cash flow

P/E, DCF and valuation multiples

Institutional and insider holdings

Analyst ratings and news sentiment

PTCT in the Healthcare

Mid Cap

Browse sector stocks →

Browse industry stocks →